Greenleaf Trust Bio Rad Laboratories, Inc. Transaction History
Greenleaf Trust
- $10.7 Billion
- Q1 2024
A detailed history of Greenleaf Trust transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Greenleaf Trust holds 682 shares of BIO stock, worth $184,187. This represents 0.0% of its overall portfolio holdings.
Number of Shares
682
Previous 695
1.87%
Holding current value
$184,187
Previous $224,000
4.91%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding BIO
# of Institutions
489Shares Held
17.8MCall Options Held
44.9KPut Options Held
79.7K-
Vanguard Group Inc Valley Forge, PA2.42MShares$654 Million0.02% of portfolio
-
Black Rock Inc. New York, NY1.48MShares$400 Million0.01% of portfolio
-
Veritas Asset Management LLP1.15MShares$310 Million3.33% of portfolio
-
State Street Corp Boston, MA874KShares$236 Million0.01% of portfolio
-
Earnest Partners LLC Atlanta, GA515KShares$139 Million0.84% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $6.65B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...